• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在固体和大孔微载体上生长的非洲绿猴肾细胞中生产1型和3型呼肠孤病毒。

Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.

作者信息

Berry J M, Barnabé N, Coombs K M, Butler M

机构信息

Department of Microbiology and Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

Biotechnol Bioeng. 1999 Jan 5;62(1):12-9. doi: 10.1002/(sici)1097-0290(19990105)62:1<12::aid-bit2>3.0.co;2-g.

DOI:10.1002/(sici)1097-0290(19990105)62:1<12::aid-bit2>3.0.co;2-g
PMID:10099508
Abstract

Two strains of reovirus were propagated in Vero cells grown in stationary or microcarriers cultures. Vero cells grown as monolayers on T-flasks or in spinner cultures of Cytodex-1 or Cultispher-G microcarriers could be infected with reovirus serotype 1, strain Lang (T1L), and serotype 3, strain Dearing (T3D). A regime of intermittent low speed stirring at reduced culture volume was critical to ensure viral infection of cells in microcarrier cultures. The virus titre increased by 3 to 4 orders of magnitude over a culture period of 150 h. Titres of the T3D reovirus strain were higher (43%) compared to those of the T1L strain in all cultures. Titres were significantly higher in T-flask and Cytodex-1 microcarrier cultures compared to Cultispher-G cultures with respect to either reovirus type. The viral productivity in the microcarrier cultures was dependent upon the multiplicity of infection (MOI) and the cell/bead ratio at the point of infection. A combination of high MOI (5 pfu/cell) and high cell/bead loading (>400 for Cytodex-1 and >1,000 for Cultispher-G) resulted in a low virus productivity per cell. However, at low MOI (0.5 pfu/cell) the virus productivity per cell was significantly higher at high cell/bead loading in cultures of either microcarrier type. The maximum virus titre (8.5 x 10(9) pfu/mL) was obtained in Cytodex-1 cultures with a low MOI (0.5 pfu/cell) and a cell/bead loading of 1,000. The virus productivity per cell in these cultures was 4,000 pfu/cell. The lower viral yield in the Cultispher-G microcarrier cultures is attributed to a decreased accessibility of the entrapped cells to viral infection. The high viral productivity from the Vero cells in Cytodex-1 cultures suggests that this is a suitable system for the development of a vaccine production system for the Reoviridae viruses.

摘要

两种呼肠孤病毒毒株在静止培养或微载体培养的Vero细胞中增殖。在T型瓶中单层生长或在Cytodex - 1或Cultispher - G微载体的旋转培养物中生长的Vero细胞可被1型朗株呼肠孤病毒(T1L)和3型迪林株呼肠孤病毒(T3D)感染。在减少培养体积的情况下进行间歇性低速搅拌的方式对于确保微载体培养中的细胞被病毒感染至关重要。在150小时的培养期内,病毒滴度增加了3至4个数量级。在所有培养物中,T3D呼肠孤病毒毒株的滴度比T1L毒株的滴度高(43%)。就任何一种呼肠孤病毒类型而言,T型瓶和Cytodex - 1微载体培养物中的滴度显著高于Cultispher - G培养物中的滴度。微载体培养物中的病毒生产力取决于感染复数(MOI)和感染时的细胞/微珠比例。高MOI(5个空斑形成单位/细胞)和高细胞/微珠负载(Cytodex - 1大于400,Cultispher - G大于1000)的组合导致每个细胞的病毒生产力较低。然而,在低MOI(0.5个空斑形成单位/细胞)时,在两种微载体类型的培养物中,高细胞/微珠负载下每个细胞的病毒生产力显著更高。在Cytodex - 1培养物中,低MOI(0.5个空斑形成单位/细胞)和细胞/微珠负载为1000时获得了最大病毒滴度(8.5×10⁹个空斑形成单位/毫升)。这些培养物中每个细胞的病毒生产力为4000个空斑形成单位/细胞。Cultispher - G微载体培养物中较低的病毒产量归因于被包裹的细胞接受病毒感染的可及性降低。Cytodex - 1培养物中Vero细胞的高病毒生产力表明这是开发呼肠孤病毒科病毒疫苗生产系统的合适体系。

相似文献

1
Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.在固体和大孔微载体上生长的非洲绿猴肾细胞中生产1型和3型呼肠孤病毒。
Biotechnol Bioeng. 1999 Jan 5;62(1):12-9. doi: 10.1002/(sici)1097-0290(19990105)62:1<12::aid-bit2>3.0.co;2-g.
2
Application of a serum-free medium for the growth of Vero cells and the production of reovirus.无血清培养基在Vero细胞生长及呼肠孤病毒生产中的应用。
Biotechnol Prog. 2000 Sep-Oct;16(5):854-8. doi: 10.1021/bp000110+.
3
Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate.在微载体上培养用于生产四血清型登革病毒的蚊子和哺乳动物细胞:病毒滴度、蚀斑形态和复制速率的变化
Biotechnol Bioeng. 2004 Mar 5;85(5):482-8. doi: 10.1002/bit.10918.
4
Rabies virus production in high vero cell density cultures on macroporous microcarriers.在大孔微载体上的高Vero细胞密度培养物中生产狂犬病病毒。
Biotechnol Bioeng. 2004 Mar 5;85(5):506-15. doi: 10.1002/bit.10917.
5
Production of yellow fever virus in microcarrier-based Vero cell cultures.在基于微载体的非洲绿猴肾细胞培养物中生产黄热病毒。
Vaccine. 2009 Oct 30;27(46):6420-3. doi: 10.1016/j.vaccine.2009.06.023. Epub 2009 Jun 24.
6
Optimization of physical parameters for cell attachment and growth on macroporous microcarriers.用于细胞在大孔微载体上附着和生长的物理参数优化。
Biotechnol Bioeng. 1996 Jun 20;50(6):627-35. doi: 10.1002/(SICI)1097-0290(19960620)50:6<627::AID-BIT3>3.0.CO;2-M.
7
Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.无血清微载体 Vero 细胞生产缺乏 NS1 基因的复制缺陷型流感候选疫苗病毒。
BMC Biotechnol. 2011 Aug 11;11:81. doi: 10.1186/1472-6750-11-81.
8
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.一种在完全无动物成分条件下于搅拌式生物反应器中培养的Vero细胞中增殖狂犬病病毒的微载体细胞培养工艺。
Vaccine. 2007 May 10;25(19):3879-89. doi: 10.1016/j.vaccine.2007.01.086. Epub 2007 Feb 5.
9
A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.一种用于在搅拌式生物反应器中Cytodex 1微载体上生长的Vero细胞中生产狂犬病病毒的新型无动物成分培养基。
Appl Microbiol Biotechnol. 2009 Nov;85(1):53-63. doi: 10.1007/s00253-009-2064-y. Epub 2009 Jun 12.
10
Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.用于灭活肠道病毒71型疫苗研发的微载体细胞培养工艺优化
Vaccine. 2004 Sep 28;22(29-30):3858-64. doi: 10.1016/j.vaccine.2004.05.037.

引用本文的文献

1
Viral Eco-Genomic Tools: Development and Implementation for Aquatic Biomonitoring.病毒生态基因组工具:在水生物监测中的开发与应用。
Int J Environ Res Public Health. 2022 Jun 23;19(13):7707. doi: 10.3390/ijerph19137707.
2
Ensuring Viral Safety of Equine Immunoglobulins during Production.在生产过程中确保马免疫球蛋白的病毒安全性。
Pharm Chem J. 2022;56(2):283-288. doi: 10.1007/s11094-022-02632-z. Epub 2022 May 7.
3
Vero cell upstream bioprocess development for the production of viral vectors and vaccines.用于生产病毒载体和疫苗的vero 细胞上游生物工艺开发。
Biotechnol Adv. 2020 Nov 15;44:107608. doi: 10.1016/j.biotechadv.2020.107608. Epub 2020 Aug 5.
4
The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody.微载体培养优化对单克隆抗体糖基化谱的影响。
Springerplus. 2013 Dec;2(1):25. doi: 10.1186/2193-1801-2-25. Epub 2013 Jan 28.
5
Enhanced production of human recombinant proteins from CHO cells grown to high densities in macroporous microcarriers.高密度培养于大孔微载体中的 CHO 细胞中重组人蛋白的增强生产。
Mol Biotechnol. 2011 Nov;49(3):263-76. doi: 10.1007/s12033-011-9401-y.
6
A novel shell-structure cell microcarrier (SSCM) for cell transplantation and bone regeneration medicine.一种新型壳结构细胞微载体(SSCM),用于细胞移植和骨再生医学。
Pharm Res. 2011 Jun;28(6):1431-41. doi: 10.1007/s11095-010-0321-5. Epub 2010 Nov 19.
7
A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism.哺乳动物正呼肠孤病毒复制周期中的进入后步骤是决定细胞嗜性的因素。
J Biol Chem. 2010 Dec 31;285(53):41604-13. doi: 10.1074/jbc.M110.176255. Epub 2010 Oct 26.
8
The effects of microcarrier culture on recombinant CHO cells under biphasic hypothermic culture conditions.微载体培养对双相低温培养条件下重组 CHO 细胞的影响。
Cytotechnology. 2009 Mar;59(2):81-91. doi: 10.1007/s10616-009-9196-x. Epub 2009 May 2.
9
A serum-free Vero production platform for a chimeric virus vaccine candidate.无血清 Vero 细胞生产平台用于生产嵌合病毒候选疫苗。
Cytotechnology. 2006 Jul;51(3):183-92. doi: 10.1007/s10616-006-9030-7. Epub 2006 Nov 16.